📰 Abt News
Page 95 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
September 30, 2023
Wendell David Associates Inc. decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 221,476 shares of the healthcare product maker’s stock after selling 645 shares during the quarter. […]
September 30, 2023
DAVENPORT & Co LLC lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 792,690 shares of the healthcare product maker’s stock after selling 15,711 shares during the quarter. DAVENPORT & Co LLC’s holdings […]
September 30, 2023
DAVENPORT & Co LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 792,690 shares of the healthcare product maker’s stock after selling 15,711 shares during the quarter. DAVENPORT & […]
September 30, 2023
Hoxton Planning & Management LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,896 shares of the healthcare product maker’s stock, valued at approximately $207,000. Several other hedge funds also […]
September 30, 2023
Advocate Group LLC trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 3.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 16,352 shares of the healthcare product maker’s stock after selling 567 shares during the quarter. Advocate Group LLC’s holdings in Abbott Laboratories were worth $1,783,000 as of its most recent SEC […]
September 30, 2023
Bailard Inc. lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 70,289 shares of the healthcare product maker’s stock after selling 6,991 shares during the period. Bailard Inc.’s holdings in […]
September 29, 2023
Sabal Trust CO lifted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1,729.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 125,066 shares of the healthcare product maker’s stock after acquiring an additional 118,230 shares […]
September 29, 2023
Gemmer Asset Management LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 34.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,778 shares of the healthcare product maker’s stock after selling 1,492 shares during the period. Gemmer Asset Management […]
September 29, 2023
Beach Investment Counsel Inc. PA cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.1% during the second quarter, Holdings Channel.com reports. The institutional investor owned 4,268 shares of the healthcare product maker’s stock after selling 700 shares during the period. Beach Investment Counsel Inc. PA’s holdings in Abbott Laboratories were […]
September 29, 2023
Baugh & Associates LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 55,407 shares of the healthcare product maker’s stock after purchasing an additional 1,124 shares during the period. Abbott Laboratories comprises […]